144 related articles for article (PubMed ID: 8389786)
1. Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma.
Hadziyannis SJ; Giannoulis G; Hadziyannis E; Kaklamani E; Alexopoulou A; Dourakis S; Trichopoulos D
J Hepatol; 1993; 17 Suppl 3():S72-7. PubMed ID: 8389786
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
3. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.
Stroffolini T; Chiaramonte M; Tiribelli C; Villa E; Simonetti RG; Rapicetta M; Stazi MA; Bertin T; Crocè SL; Trande P
J Hepatol; 1992 Nov; 16(3):360-3. PubMed ID: 1336785
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic.
Tsega E; Nordenfelt E; Hansson BG
Trans R Soc Trop Med Hyg; 1995; 89(2):171-4. PubMed ID: 7539952
[TBL] [Abstract][Full Text] [Related]
7. Minimal role of hepatitis C virus infection in childhood liver diseases in an area hyperendemic for hepatitis B infection.
Chang MH; Lee CY; Chen DS
J Med Virol; 1993 Aug; 40(4):322-5. PubMed ID: 8228924
[TBL] [Abstract][Full Text] [Related]
8. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma.
Lee SD; Lee FY; Wu JC; Hwang SJ; Wang SS; Lo KJ
Cancer; 1992 Jan; 69(2):342-5. PubMed ID: 1309428
[TBL] [Abstract][Full Text] [Related]
10. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area.
Lee HS; Han CJ; Kim CY
Cancer; 1993 Nov; 72(9):2564-7. PubMed ID: 8402477
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection in patients with chronic liver diseases in an endemic area for hepatitis B virus infection.
Liaw YF; Chien RN; Sheen IS; Lin DY; Lin HH; Chu CM
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():167-9. PubMed ID: 1909260
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma.
Kaklamani E; Trichopoulos D; Tzonou A; Zavitsanos X; Koumantaki Y; Hatzakis A; Hsieh CC; Hatziyannis S
JAMA; 1991 Apr; 265(15):1974-6. PubMed ID: 1848908
[TBL] [Abstract][Full Text] [Related]
14. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?
Leung NW; Tam JS; Lai JY; Leung TW; Lau WY; Shiu W; Li AK
Cancer; 1992 Jul; 70(1):40-4. PubMed ID: 1318777
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays.
Kuper HE; Tzonou A; Kaklamani E; Hadziyannis S; Tasopoulos N; Lagiou P; Trichopoulos D; Stuver S
Cancer Causes Control; 2000 Feb; 11(2):171-5. PubMed ID: 10710202
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.
Colombo M; Kuo G; Choo QL; Donato MF; Del Ninno E; Tommasini MA; Dioguardi N; Houghton M
Lancet; 1989 Oct; 2(8670):1006-8. PubMed ID: 2572740
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.
Marusawa H; Osaki Y; Kimura T; Ito K; Yamashita Y; Eguchi T; Kudo M; Yamamoto Y; Kojima H; Seno H; Moriyasu F; Chiba T
Gut; 1999 Aug; 45(2):284-8. PubMed ID: 10403743
[TBL] [Abstract][Full Text] [Related]
19. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan.
Hamasaki K; Nakata K; Tsutsumi T; Tsuruta S; Nakao K; Kato Y; Shima M; Koji T; Nagataki S
J Med Virol; 1993 Jun; 40(2):146-9. PubMed ID: 8395554
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.
Chen DS; Kuo GC; Sung JL; Lai MY; Sheu JC; Chen PJ; Yang PM; Hsu HM; Chang MH; Chen CJ
J Infect Dis; 1990 Oct; 162(4):817-22. PubMed ID: 2169497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
